Scribe Therapeutics拟美股IPO募1.072亿美元
2026-07-20 12:25:02
据彭博社报道，礼来支持的Scribe Therapeutics Inc.寻求在美国首次公开募股中最多募集1.072亿美元。该公司是一家处于临床阶段的基因疗法开发商，聚焦心脏病治疗。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
巴克莱上调Lumentum评级Next article：
贵金属 | 国际现货黄金短线震荡上行
